- Merck & Co. reports robust Q1 2025 revenue with significant contributions from KEYTRUDA.
- Analysts set an average one-year target price of $110.25 for Merck, indicating potential growth.
- GuruFocus estimates a significant upside in Merck's stock value based on historical and forecast data.
Merck & Co. (MRK, Financial) showcased strong financial performance in the first quarter of 2025, achieving a revenue of $15.5 billion. This impressive result was significantly bolstered by its oncology powerhouse, KEYTRUDA, which alone garnered $7.2 billion. New breakthroughs, WINREVAIR and CAPVAXIVE, also made notable contributions to this quarter's earnings, underscoring Merck's innovative edge. The company remains steadfast in driving long-term growth through strategic investments in both U.S. manufacturing and research and development.
Analyst Price Targets and Recommendations
Experts on Wall Street hold an optimistic outlook for Merck & Co Inc (MRK, Financial), with 22 analysts offering a one-year average price target of $110.25. This figure is bracketed by a high estimate of $146.00 and a low of $89.00, pointing to an upside potential of 38.63% from its current trading price of $79.53. Further insights and detailed estimates can be explored on the Merck & Co Inc (MRK) Forecast page.
With 27 brokerage firms weighing in, Merck & Co Inc's (MRK, Financial) average brokerage recommendation stands at 2.1, suggesting an "Outperform" status. The recommendation scale, ranging from 1 to 5, indicates robust confidence in the stock, where 1 represents a Strong Buy and 5 suggests a Sell.
GF Value and Growth Potential
According to GuruFocus estimates, Merck's GF Value over the next year is projected at $120.96, representing a promising upside of 52.09% from the current price of $79.5294. The GF Value is a critical metric that reflects the fair market value of the stock, derived from historical trading multiples, past business growth, and future performance expectations. Investors seeking more comprehensive data can visit the Merck & Co Inc (MRK, Financial) Summary page.
